Xtx Topco LTD Novo Nordisk A S Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Xtx Topco LTD holds 6,129 shares of NVO stock, worth $661,993. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,129

Previous 24,890 75.38%

Holding current value

$661,993

Previous $3.55 Million 79.48%

% of portfolio

0.06%

Previous 0.32%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $2.23 Million - $2.73 Million	-18,761 Reduced 75.38%	6,129 $729,000
Q2 2024 Aug 12, 2024	BUY	$122.71 - $146.91 $2.51 Million - $3.01 Million	20,482 Added 464.66%	24,890 $3.55 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $151,429 - $201,569	-1,483 Reduced 25.17%	4,408 $565,000
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $517,111 - $621,205	5,891 New	5,891 $609,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $355,010 - $392,951	2,276 New	2,276 $368,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $735,796 - $970,992	7,175 New	7,175 $970,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $223,067 - $269,645	-2,396 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $364,535 - $445,138	-3,802 Reduced 61.34%	2,396 $268,000
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $523,235 - $660,830	6,198 New	6,198 $595,000
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $390,533 - $489,234	-5,772 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $387,070 - $437,633	5,772 New	5,772 $389,000

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account